C4 Therapeutics (CCCC) PT Raised to $7 at Barclays
Tweet Send to a Friend
Barclays analyst Etzer Darout raised the price target on C4 Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
